Romo, Liezle .
HRN: 05-44-06 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/20/2023
CEFUROXIME 500MG (TAB)
09/20/2023
09/27/2023
PO
500mg
BID X 7 Days
S/P NAVD With RMLE And Repair
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes